chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Headache, Myalgia
Clinical narrative: shaking; headache; muscle aches; extreme fatigue; chills; Febrile; This spontaneous case was reported by an other health care professional and describes the occurrence of TREMOR (shaking), HEADACHE (headache), MYALGIA (muscle aches), FATIGUE (extreme fatigue) and CHILLS (chills) in a 34-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031M20A and 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Feb-2021, the patient experienced TREMOR (shaking), HEADACHE (headache), MYALGIA (muscle aches), FATIGUE (extreme fatigue), CHILLS (chills) and PYREXIA (Febrile). The patient was treated with PARACETAMOL (TYLENOL) for Fever and Headache, at an unspecified dose and frequency and IBUPROFEN for Fever and Headache, at an unspecified dose and frequency. On 15-Feb-2021, TREMOR (shaking), MYALGIA (muscle aches), FATIGUE (extreme fatigue), CHILLS (chills) and PYREXIA (Febrile) had resolved. At the time of the report, HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Feb-2021, Body temperature: inconclusive (Inconclusive) Inconclusive.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: Updated reporter's details, updated second dose details,updated treatment details and changed event (headache) outcome from not recovered/not resolved to unknown.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Tremor
Clinical narrative: shaking; headache; muscle aches; extreme fatigue; chills; Febrile; This spontaneous case was reported by an other health care professional and describes the occurrence of TREMOR (shaking), HEADACHE (headache), MYALGIA (muscle aches), FATIGUE (extreme fatigue) and CHILLS (chills) in a 34-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031M20A and 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Feb-2021, the patient experienced TREMOR (shaking), HEADACHE (headache), MYALGIA (muscle aches), FATIGUE (extreme fatigue), CHILLS (chills) and PYREXIA (Febrile). The patient was treated with PARACETAMOL (TYLENOL) for Fever and Headache, at an unspecified dose and frequency and IBUPROFEN for Fever and Headache, at an unspecified dose and frequency. On 15-Feb-2021, TREMOR (shaking), MYALGIA (muscle aches), FATIGUE (extreme fatigue), CHILLS (chills) and PYREXIA (Febrile) had resolved. At the time of the report, HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Feb-2021, Body temperature: inconclusive (Inconclusive) Inconclusive.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: Updated reporter's details, updated second dose details,updated treatment details and changed event (headache) outcome from not recovered/not resolved to unknown.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: I got very dizzy since then; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (I got very dizzy since then) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 05-Feb-2021, the patient experienced DIZZINESS (I got very dizzy since then). At the time of the report, DIZZINESS (I got very dizzy since then) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Cough, Nausea, Productive cough, Vomiting
Clinical narrative: coughing; Phlegm in the throat; Vomiting; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (coughing), PRODUCTIVE COUGH (Phlegm in the throat), VOMITING (Vomiting) and NAUSEA (Nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Pneumonia (Previously had pneumonia and took antibiotics for it.).    On 24-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On an unknown date, the patient experienced COUGH (coughing), PRODUCTIVE COUGH (Phlegm in the throat), VOMITING (Vomiting) and NAUSEA (Nausea). At the time of the report, COUGH (coughing), PRODUCTIVE COUGH (Phlegm in the throat), VOMITING (Vomiting) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication were not provided. Treatment information were not provided.   Reporter did not allow further contact
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Carpal tunnel syndrome, Fatigue, Headache, Infectious mononucleosis
Clinical narrative: Positive test result of mono; Severe fatigue; headache; Body ache; severe back pain; heaviness in arm; numbness and tingling in hands; soreness; This spontaneous case was reported by an other health care professional and describes the occurrence of LIMB DISCOMFORT (heaviness in arm), CARPAL TUNNEL SYNDROME (numbness and tingling in hands), INFECTIOUS MONONUCLEOSIS (Positive test result of mono), BACK PAIN (severe back pain) and FATIGUE (Severe fatigue) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 089K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Jan-2021, the patient experienced LIMB DISCOMFORT (heaviness in arm), CARPAL TUNNEL SYNDROME (numbness and tingling in hands) and VACCINATION SITE PAIN (soreness). On 11-Jan-2021, the patient experienced BACK PAIN (severe back pain). On 13-Jan-2021, the patient experienced FATIGUE (Severe fatigue), HEADACHE (headache) and MYALGIA (Body ache). On 20-Jan-2021, the patient experienced INFECTIOUS MONONUCLEOSIS (Positive test result of mono). The patient was treated with IBUPROFEN ongoing since an unknown date at a dose of 1 dosage form; VITAMIN B NOS ongoing since an unknown date at a dose of 1 dosage form and COLECALCIFEROL (D3) ongoing since an unknown date at a dose of 1 dosage form. On 11-Jan-2021, LIMB DISCOMFORT (heaviness in arm), CARPAL TUNNEL SYNDROME (numbness and tingling in hands) and VACCINATION SITE PAIN (soreness) had resolved. On 14-Jan-2021, BACK PAIN (severe back pain) had resolved. On 03-Feb-2021, INFECTIOUS MONONUCLEOSIS (Positive test result of mono), FATIGUE (Severe fatigue), HEADACHE (headache) and MYALGIA (Body ache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant was provided.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort, Myalgia, Vaccination site pain
Clinical narrative: Positive test result of mono; Severe fatigue; headache; Body ache; severe back pain; heaviness in arm; numbness and tingling in hands; soreness; This spontaneous case was reported by an other health care professional and describes the occurrence of LIMB DISCOMFORT (heaviness in arm), CARPAL TUNNEL SYNDROME (numbness and tingling in hands), INFECTIOUS MONONUCLEOSIS (Positive test result of mono), BACK PAIN (severe back pain) and FATIGUE (Severe fatigue) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 089K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Jan-2021, the patient experienced LIMB DISCOMFORT (heaviness in arm), CARPAL TUNNEL SYNDROME (numbness and tingling in hands) and VACCINATION SITE PAIN (soreness). On 11-Jan-2021, the patient experienced BACK PAIN (severe back pain). On 13-Jan-2021, the patient experienced FATIGUE (Severe fatigue), HEADACHE (headache) and MYALGIA (Body ache). On 20-Jan-2021, the patient experienced INFECTIOUS MONONUCLEOSIS (Positive test result of mono). The patient was treated with IBUPROFEN ongoing since an unknown date at a dose of 1 dosage form; VITAMIN B NOS ongoing since an unknown date at a dose of 1 dosage form and COLECALCIFEROL (D3) ongoing since an unknown date at a dose of 1 dosage form. On 11-Jan-2021, LIMB DISCOMFORT (heaviness in arm), CARPAL TUNNEL SYNDROME (numbness and tingling in hands) and VACCINATION SITE PAIN (soreness) had resolved. On 14-Jan-2021, BACK PAIN (severe back pain) had resolved. On 03-Feb-2021, INFECTIOUS MONONUCLEOSIS (Positive test result of mono), FATIGUE (Severe fatigue), HEADACHE (headache) and MYALGIA (Body ache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant was provided.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Vaccination site erythema, Vaccination site pruritus, Vaccination site reaction, Vaccination site swelling
Clinical narrative: Chills; Swelling of the injection site; Redness of the injection site; Itchiness on the injection arm.; Welts on the injection arm.; Knots on the injection arm.; A spontaneous report was received from a consumer concerning herself, who is a 70-years-old female patient received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events chills, swelling of the injection site, redness of the injection site, itchiness on the injection arm, welts on the injection arm, knots on the injection arm.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 24 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 013A21A) intramuscularly for prophylaxis of COVID-19 infection.  On 24 Feb 2021, the patient experienced the events chills, swelling and redness of the injection site, itchiness, welts and a knot on the injection arm. Side effects have begun to subsided but are still present at this time.  Treatment for the event included ice/heat.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events chills, swelling, redness, itchiness, welts, knots at site was recovery at the time of reporting.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site urticaria
Clinical narrative: Chills; Swelling of the injection site; Redness of the injection site; Itchiness on the injection arm.; Welts on the injection arm.; Knots on the injection arm.; A spontaneous report was received from a consumer concerning herself, who is a 70-years-old female patient received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events chills, swelling of the injection site, redness of the injection site, itchiness on the injection arm, welts on the injection arm, knots on the injection arm.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 24 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 013A21A) intramuscularly for prophylaxis of COVID-19 infection.  On 24 Feb 2021, the patient experienced the events chills, swelling and redness of the injection site, itchiness, welts and a knot on the injection arm. Side effects have begun to subsided but are still present at this time.  Treatment for the event included ice/heat.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events chills, swelling, redness, itchiness, welts, knots at site was recovery at the time of reporting.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: Chills; Low grade fever; This spontaneous case was reported by an other health care professional and describes the occurrence of CHILLS (Chills) and PYREXIA (Low grade fever) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHILLS (Chills) and PYREXIA (Low grade fever). At the time of the report, CHILLS (Chills) and PYREXIA (Low grade fever) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Reaction was hot; Reaction became swollen and bigger; Redness; Tenderness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Reaction was hot), VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE PAIN (Tenderness) and VACCINATION SITE SWELLING (Reaction became swollen and bigger) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness) and VACCINATION SITE PAIN (Tenderness). On 18-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Reaction was hot) and VACCINATION SITE SWELLING (Reaction became swollen and bigger). The patient was treated with PREDNISONE ongoing since an unknown date at a dose of 6 day regimen of prednisone; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date at a dose of 1 dosage form and HYDROCORTISONE ongoing since an unknown date at a dose of 1 dosage form. On 09-Feb-2021, VACCINATION SITE ERYTHEMA (Redness) and VACCINATION SITE PAIN (Tenderness) had resolved. At the time of the report, VACCINATION SITE WARMTH (Reaction was hot) and VACCINATION SITE SWELLING (Reaction became swollen and bigger) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant was provided.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Gait disturbance
Clinical narrative: a lot of pain in their left knee; cannot walk right; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (a lot of pain in their left knee) and GAIT DISTURBANCE (cannot walk right) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.    Co-suspect product included non-company product PARACETAMOL (TYLENOL) for an unknown indication.    No Medical History information was reported.   On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient started PARACETAMOL (TYLENOL) (unknown route) at an unspecified dose. On 08-Feb-2021, the patient experienced ARTHRALGIA (a lot of pain in their left knee) and GAIT DISTURBANCE (cannot walk right). At the time of the report, ARTHRALGIA (a lot of pain in their left knee) and GAIT DISTURBANCE (cannot walk right) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pruritus, Rash morbilliform, Urticaria
Clinical narrative: Hives; Very itchy; Arm hurt a bit; Looked like she had measles; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives), PRURITUS (Very itchy), PAIN IN EXTREMITY (Arm hurt a bit) and RASH MORBILLIFORM (Looked like she had measles) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     The patient's past medical history included UTI and Surgery (She had emergency surgery from an UTI and blood transfusion as she was internally bleeding.).    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced URTICARIA (Hives), PRURITUS (Very itchy), PAIN IN EXTREMITY (Arm hurt a bit) and RASH MORBILLIFORM (Looked like she had measles). At the time of the report, URTICARIA (Hives), PRURITUS (Very itchy), PAIN IN EXTREMITY (Arm hurt a bit) and RASH MORBILLIFORM (Looked like she had measles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pruritus, Rash, Skin burning sensation
Clinical narrative: rash on the front part of your arm; Extreme fatigue; itchiness; Burning rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash on the front part of your arm), FATIGUE (Extreme fatigue), PRURITUS (itchiness) and SKIN BURNING SENSATION (Burning rash) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004M20A and 023M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported). Concomitant products included VITAMINS NOS for an unknown indication.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced RASH (rash on the front part of your arm), FATIGUE (Extreme fatigue), PRURITUS (itchiness) and SKIN BURNING SENSATION (Burning rash). At the time of the report, RASH (rash on the front part of your arm) was resolving and FATIGUE (Extreme fatigue), PRURITUS (itchiness) and SKIN BURNING SENSATION (Burning rash) outcome was unknown.            No concomitant medication was provided.  No treatment details were provided.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: nauseous; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nauseous) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced NAUSEA (nauseous). At the time of the report, NAUSEA (nauseous) was resolving.            No relevant concomitant medications were reported. Treatment information not provided.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Lip swelling, Rash
Clinical narrative: Had swelling in his lower lip; Rash around buttocks and waist area; This spontaneous case was reported by a consumer and describes the occurrence of LIP SWELLING (Had swelling in his lower lip) and RASH (Rash around buttocks and waist area) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     Concurrent medical conditions included Glaucoma.   On 23-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced LIP SWELLING (Had swelling in his lower lip) and RASH (Rash around buttocks and waist area). At the time of the report, LIP SWELLING (Had swelling in his lower lip) and RASH (Rash around buttocks and waist area) outcome was unknown.            No relevant concomitant medications were reported. Treatment information was not provided.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Myalgia, Rash
Clinical narrative: Rash on the back; Joint ache; Muscle ache; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash on the back), ARTHRALGIA (Joint ache), MYALGIA (Muscle ache) and FATIGUE (Fatigue) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced RASH (Rash on the back), ARTHRALGIA (Joint ache), MYALGIA (Muscle ache) and FATIGUE (Fatigue). At the time of the report, RASH (Rash on the back), ARTHRALGIA (Joint ache), MYALGIA (Muscle ache) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided. No relevant concomitant medications were reported.   This case was linked to, INC.-MOD-2021-027707 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: Follow-up received on 28-APR-2021and contains non significant information. Reporter details was updated. On 19-Jun-2021: follow-up received on 19-JUN-2021 and contains No new information; Sender's Comments: INC.-MOD-2021-027707:cross link.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Eye pain, Feeling abnormal, Headache, Nausea
Clinical narrative: No Medical History information was reported.    On 23-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced EYE PAIN (Pain behind eye), FEELING ABNORMAL (brain fog), PAIN (Sharp shooting pain in right side of brain), ARTHRALGIA (Pain in shoulder), NAUSEA (Nausea), HEADACHE (Headache) and VACCINATION SITE PAIN (vaccination site pain). At the time of the report, EYE PAIN (Pain behind eye), FEELING ABNORMAL (brain fog), PAIN (Sharp shooting pain in right side of brain), HEADACHE (Headache) and VACCINATION SITE PAIN (vaccination site pain) had not resolved and ARTHRALGIA (Pain in shoulder) and NAUSEA (Nausea) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided No treatment information provided.   Most recent FOLLOW-UP information incorporated above includes: On 26-Feb-2021: Reporter, patient details and events added On 29-Apr-2021: five events are added
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Vaccination site pain
Clinical narrative: No Medical History information was reported.    On 23-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced EYE PAIN (Pain behind eye), FEELING ABNORMAL (brain fog), PAIN (Sharp shooting pain in right side of brain), ARTHRALGIA (Pain in shoulder), NAUSEA (Nausea), HEADACHE (Headache) and VACCINATION SITE PAIN (vaccination site pain). At the time of the report, EYE PAIN (Pain behind eye), FEELING ABNORMAL (brain fog), PAIN (Sharp shooting pain in right side of brain), HEADACHE (Headache) and VACCINATION SITE PAIN (vaccination site pain) had not resolved and ARTHRALGIA (Pain in shoulder) and NAUSEA (Nausea) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided No treatment information provided.   Most recent FOLLOW-UP information incorporated above includes: On 26-Feb-2021: Reporter, patient details and events added On 29-Apr-2021: five events are added
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Decreased appetite, Fatigue, Pyrexia
Clinical narrative: Fever 101 F; Loss of appetite; Loss of sense of Smell; Loss of sense of Taste; Very Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (Loss of appetite), ANOSMIA (Loss of sense of Smell), AGEUSIA (Loss of sense of Taste), FATIGUE (Very Fatigue) and PYREXIA (Fever 101 F) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027L20A and 010M20A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma, Hashimoto's thyroiditis and Peripheral neuropathy.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Jan-2021, the patient experienced DECREASED APPETITE (Loss of appetite), ANOSMIA (Loss of sense of Smell), AGEUSIA (Loss of sense of Taste) and FATIGUE (Very Fatigue). On 10-Feb-2021, the patient experienced PYREXIA (Fever 101 F). On 15-Jan-2021, FATIGUE (Very Fatigue) had resolved. On 11-Feb-2021, PYREXIA (Fever 101 F) had resolved. At the time of the report, DECREASED APPETITE (Loss of appetite), ANOSMIA (Loss of sense of Smell) and AGEUSIA (Loss of sense of Taste) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative (Negative) negative.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: Fever 101 F; Loss of appetite; Loss of sense of Smell; Loss of sense of Taste; Very Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (Loss of appetite), ANOSMIA (Loss of sense of Smell), AGEUSIA (Loss of sense of Taste), FATIGUE (Very Fatigue) and PYREXIA (Fever 101 F) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027L20A and 010M20A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma, Hashimoto's thyroiditis and Peripheral neuropathy.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Jan-2021, the patient experienced DECREASED APPETITE (Loss of appetite), ANOSMIA (Loss of sense of Smell), AGEUSIA (Loss of sense of Taste) and FATIGUE (Very Fatigue). On 10-Feb-2021, the patient experienced PYREXIA (Fever 101 F). On 15-Jan-2021, FATIGUE (Very Fatigue) had resolved. On 11-Feb-2021, PYREXIA (Fever 101 F) had resolved. At the time of the report, DECREASED APPETITE (Loss of appetite), ANOSMIA (Loss of sense of Smell) and AGEUSIA (Loss of sense of Taste) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative (Negative) negative.
Age: 78.0
Sex: U
Vaccine: COVID19
Symptoms: Malaise, Myalgia, Vaccination site erythema, Vaccination site pain, Vaccination site warmth
Clinical narrative: Arm  was sore; Body was aching; hot; Red; Felt a little sick; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Felt a little sick), VACCINATION SITE WARMTH (hot), VACCINATION SITE ERYTHEMA (Red), VACCINATION SITE PAIN (Arm  was sore) and MYALGIA (Body was aching) in a 78-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042L20A and 023M20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Codeine).   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Feb-2021, the patient experienced MALAISE (Felt a little sick). On 24-Feb-2021, the patient experienced VACCINATION SITE WARMTH (hot), VACCINATION SITE ERYTHEMA (Red) and MYALGIA (Body was aching). On an unknown date, the patient experienced VACCINATION SITE PAIN (Arm  was sore). At the time of the report, MALAISE (Felt a little sick), VACCINATION SITE WARMTH (hot), VACCINATION SITE ERYTHEMA (Red), VACCINATION SITE PAIN (Arm  was sore) and MYALGIA (Body was aching) outcome was unknown. Not Provided          No concomitant was provided. Patient treatment information was not provided.
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm soreness) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm soreness). On 27-Feb-2021, PAIN IN EXTREMITY (arm soreness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication information was provided. No treatment medication information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: Follow up Information was received on 28-APR-2021and added the stop date of the event and patient declined further follow-up
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus
Clinical narrative: itchy; redness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itchy) and VACCINATION SITE ERYTHEMA (redness) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (itchy) and VACCINATION SITE ERYTHEMA (redness). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 UNK. At the time of the report, VACCINATION SITE PRURITUS (itchy) and VACCINATION SITE ERYTHEMA (redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. Other treatment details included alcohol.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy, Fatigue, Pyrexia
Clinical narrative: Fever; Extreme fatigue; Pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnant), PYREXIA (Fever) and FATIGUE (Extreme fatigue) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M0A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 07-Jul-2021. On 20-Jan-2021, the patient experienced EXPOSURE DURING PREGNANCY (Pregnant). On 23-Feb-2021, the patient experienced PYREXIA (Fever) and FATIGUE (Extreme fatigue). On 23-Feb-2021, EXPOSURE DURING PREGNANCY (Pregnant) had resolved. At the time of the report, PYREXIA (Fever) and FATIGUE (Extreme fatigue) outcome was unknown.            Concomitant medications was not reported . T Treatment history was not reported .   This case was linked to MOD-2021-010142 (Patient Link).   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: TCR received contains , Patient denied further Follow up .
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Hyperhidrosis, Pyrexia, Tremor
Clinical narrative: sweats at night; shakes; had the "shakes; fever on and off (101F); This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweats at night), TREMOR (shakes), CHILLS (had the "shakes) and PYREXIA (fever on and off (101F)) in an 89-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, the patient experienced TREMOR (shakes), CHILLS (had the "shakes) and PYREXIA (fever on and off (101F)). On 25-Feb-2021, the patient experienced HYPERHIDROSIS (sweats at night). At the time of the report, HYPERHIDROSIS (sweats at night), TREMOR (shakes), CHILLS (had the "shakes) and PYREXIA (fever on and off (101F)) outcome was unknown.            No treatment information was provided. Patient had Prednisone regimen between the 1st dose and 2nd dose for a previous undiagnosed cough. Action taken with mRNA-123 is not applicable.   Reporter did not allow further contact
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site discolouration, Vaccination site erythema, Vaccination site warmth
Clinical narrative: edges seem to be irregular, a little lighter; warm; redness appeared around the site, getting larger; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (edges seem to be irregular, a little lighter), VACCINATION SITE WARMTH (warm) and VACCINATION SITE ERYTHEMA (redness appeared around the site, getting larger) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for Allergy, ACETYLSALICYLIC ACID (BABY ASPIRIN) and MULTIVITAMIN & MINERAL for an unknown indication.   On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Feb-2021, the patient experienced VACCINATION SITE WARMTH (warm) and VACCINATION SITE ERYTHEMA (redness appeared around the site, getting larger). On 26-Feb-2021, the patient experienced VACCINATION SITE DISCOLOURATION (edges seem to be irregular, a little lighter). On 25-Feb-2021, VACCINATION SITE ERYTHEMA (redness appeared around the site, getting larger) had resolved. At the time of the report, VACCINATION SITE DISCOLOURATION (edges seem to be irregular, a little lighter) and VACCINATION SITE WARMTH (warm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient was taking 2x high blood pressure medication and cholesterol medication. Patient Treatment information was not provided.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Chills, Heart rate increased
Clinical narrative: chills; pulse was up; blood pressure was up; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HEART RATE INCREASED (pulse was up), BLOOD PRESSURE INCREASED (blood pressure was up) and CHILLS (chills) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No medical history information provided by the reporter.  Concomitant products included LISINOPRIL and ERGOCALCIFEROL, RETINOL PALMITATE (VITAMINS) for an unknown indication.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, the patient experienced HEART RATE INCREASED (pulse was up) and BLOOD PRESSURE INCREASED (blood pressure was up). On an unknown date, the patient experienced CHILLS (chills). At the time of the report, HEART RATE INCREASED (pulse was up) and BLOOD PRESSURE INCREASED (blood pressure was up) had resolved and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 12-Mar-2021: New info about dose, new AEs added.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Device connection issue, Underdose
Clinical narrative: Syringe malfunctioned so some of the dose did not get injected; Syringe malfunctioned so some of the dose did not get injected; This spontaneous case was reported by a pharmacist and describes the occurrence of UNDERDOSE (Syringe malfunctioned so some of the dose did not get injected) and DEVICE CONNECTION ISSUE (Syringe malfunctioned so some of the dose did not get injected) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 007M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Feb-2021, the patient experienced UNDERDOSE (Syringe malfunctioned so some of the dose did not get injected) and DEVICE CONNECTION ISSUE (Syringe malfunctioned so some of the dose did not get injected). At the time of the report, UNDERDOSE (Syringe malfunctioned so some of the dose did not get injected) and DEVICE CONNECTION ISSUE (Syringe malfunctioned so some of the dose did not get injected) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications was not provided by the reporter.  Treatment information was not provided.  After receiving 2nd dose patient didn't  have adverse reactions.   Most recent FOLLOW-UP information incorporated above includes: On 08-Apr-2021: Follow up received on 08-APR-2021 included updated reporter information, patient information, vaccine information and AE information.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia, Pyrexia, Vaccination site pain
Clinical narrative: chills; headache; achiness; fever; vomited; tenderness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), HEADACHE (headache), VACCINATION SITE PAIN (tenderness at injection site), MYALGIA (achiness) and PYREXIA (fever) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042L20A and 043L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy and Drug allergy (Talwin, Lisinopril).   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced VACCINATION SITE PAIN (tenderness at injection site). On 25-Feb-2021, the patient experienced CHILLS (chills), HEADACHE (headache), MYALGIA (achiness), PYREXIA (fever) and VOMITING (vomited). At the time of the report, CHILLS (chills), HEADACHE (headache), VACCINATION SITE PAIN (tenderness at injection site), MYALGIA (achiness), PYREXIA (fever) and VOMITING (vomited) outcome was unknown.            there are no concomitant medication mentioned :no medical history mentioned , no lab data mentioned. Patient treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: Follow up received and contains no new information (declined further contact)
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: chills; headache; achiness; fever; vomited; tenderness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), HEADACHE (headache), VACCINATION SITE PAIN (tenderness at injection site), MYALGIA (achiness) and PYREXIA (fever) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042L20A and 043L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy and Drug allergy (Talwin, Lisinopril).   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced VACCINATION SITE PAIN (tenderness at injection site). On 25-Feb-2021, the patient experienced CHILLS (chills), HEADACHE (headache), MYALGIA (achiness), PYREXIA (fever) and VOMITING (vomited). At the time of the report, CHILLS (chills), HEADACHE (headache), VACCINATION SITE PAIN (tenderness at injection site), MYALGIA (achiness), PYREXIA (fever) and VOMITING (vomited) outcome was unknown.            there are no concomitant medication mentioned :no medical history mentioned , no lab data mentioned. Patient treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: Follow up received and contains no new information (declined further contact)
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Incorrect route of product administration, Vaccination site haemorrhage
Clinical narrative: Administered in the right triceps via subcutaneous route/told nurse she didnt give it correctly; A little bleeding at the site; Feeling shocked; A spontaneous report was received from a nurse concerning a 69-year-old, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced administered in the right triceps via subcutaneous route/ incorrect route of vaccine administration, a little bleeding at the site/ vaccination site hemorrhage, feeling shocked, concerned about efficacy, told nurse she didn't give it correctly.  The patient's medical history, as provided by the reporter included thyroid nodule removal, allergies to antibiotic, streptomycin. Concomitant medications was levothyroxine 50mcg reported.  On 25 Feb 2021, approximately six hours prior to the onset of the events, the patient received their second of two planned doses of mRNA-1273 (Lot number: 010AZ1A) subcutaneous in the unknown site for prophylaxis of COVID-19 infection.   On 25 Feb 2021, prior to receiving mRNA-1273, the patient felt administered in the right triceps via subcutaneous route, a little bleeding at the site, feeling shocked, concerned about efficacy, told nurse she didn't give it correctly. Treatment for the events were not included.  Action taken with mRNA-1273 in response to the events was not  applicable reported.   The events, administered in the right triceps via subcutaneous route, a little bleeding at the site, feeling shocked, concerned about efficacy, told nurse she didn't give it correctly were considered resolved on 25 Feb 2021.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 17 year old patient received the first dose; A spontaneous report was received from a pharmacist concerning a 17-year-old, male patient, who received Moderna's COVID-19 vaccine (mRNA-1273).  The patient's medical history, was not  provided by the reporter. No Concomitant medications reported   On 28 Jan 2021, the patient received his first of two planned doses of mRNA-1273 (Lot number: 028L20A) intramuscularly in the right arm for prophylaxis of COVID-19 infection.   They noticed that the dose was administered to a 17 year old patient and only when the patient came for the second dose on 25 Feb 2021, however, they did not administer the second dose.  Action taken was unknown.  The outcome of product administered to patient of inappropriate age was considered resolved.; Reporter's Comments: This report refers to a case of product administered to patient of inappropriate age (17 year old male) for mRNA-1273 (lot number 028L20A) with no associated AEs reported.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site movement impairment, Vaccination site pain
Clinical narrative: cannot raise arm; very sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (cannot raise arm) and VACCINATION SITE PAIN (very sore arm) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (cannot raise arm) and VACCINATION SITE PAIN (very sore arm). At the time of the report, VACCINATION SITE MOVEMENT IMPAIRMENT (cannot raise arm) and VACCINATION SITE PAIN (very sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant was provided. No treatment medication was reported.